You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國藥現代(600420.SH):培哚普利吲達帕胺片獲得藥品註冊證書

格隆匯6月30日丨國藥現代(600420.SH)公佈,公司全資子公司國藥集團工業有限公司(稱國藥工業)收到國家藥品監督管理局覈準簽發的培哚普利吲達帕胺片《藥品註冊證書》。培哚普利吲達帕胺片是由培哚普利叔丁胺和吲達帕胺組成的複方片劑,用於治療成人原發性高血壓。本品適用於單獨服用培哚普利不能完全控制血壓的患者。

本次國藥工業的培哚普利吲達帕胺片獲得藥品註冊證書並視同通過一致性評價,將進一步豐富公司心血管領域的製劑產品羣,有利於進一步增強公司在相關用藥領域的綜合市場競爭力,爲公司未來發展帶來積極影響。上述事項對公司當前經營業績不會產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account